行政助理实习生
广州燃石医学检验所有限公司
- 公司规模:1000-5000人
- 公司性质:民营公司
- 公司行业:制药/生物工程
职位信息
- 发布日期:2019-10-30
- 工作地点:广州-海珠区
- 招聘人数:2人
- 工作经验:无工作经验
- 学历要求:本科
- 职位月薪:100元/天
- 职位类别:行政专员/助理 前台接待/总机/接待生
职位描述
- 协助前台小姐姐,做好前台工作管理,包括但不限于各项来访接待任务,快递的往来管理;
- 协助行政支持工作,各项员工福利、文化活动的落地,支持每月员工活动的组织与开展;
- 协助做好公司行政事务,比如办公用品库存及发放管理、合同及相关档案整理等;
- 协助行政项目工作,比如装修项目、公司内外部环境的管理、办公设施的维护,包括办公场所的整体布置;
- 协助资产管理,定期完成固定资产盘点工作;
【岗位要求】
- 在校大学生,保证每周工作日出勤三天以上;
- 熟练使用Word、Excel,PS等办公软件,各种办公自动化设备;
- 热爱行政工作,善于发现并解决问题,具备建立与各部门良好沟通与协作关系的能力,关注员工体验;
- 有丰富多彩的想法,为我们的各种团建活动提供有趣味的元素,有过社团经验和大型活动策划经验(加分项);
你可以获得:
- 如果你展示了出色的能力,我们非常乐意带你参与到更多项目,对个人能力提升大有益处;
- 直线协助很nice的前台小姐姐,还有很亲切的部门boss;
- 各种小零食、咖啡和养生茶供应,各种团建活动等你策划;
- 100/天的实习津贴,是个超棒der实习机会!
加入我们实习生行列,进入燃石"Young计划",在部门经理的指导下,把握各种学习机会,接触行业大牛,还可以收获优厚的待遇!
职能类别:行政专员/助理前台接待/总机/接待生
公司介绍
关于燃石医学
燃石医学(纳斯达克代码:BNR)成立于2014年,公司使命为“用科学守护生命之光”,专注于为肿瘤精准医疗提供具有临床价值的二代基因测序(NGS)。公司业务及研发方向主要覆盖:1)基于NGS的肿瘤患病人群检测,6年间,燃石累计检测样本超过18.5万例,在中国市场份额领跑行业;2)基于NGS的癌症早检,目前已经进入临床验证阶段。
燃石医学于2018年7月率先获国家药品监督管理局(NMPA)颁发的中国肿瘤NGS检测试剂盒,在体外诊断领域具有里程碑式意义。实验室获得广东省临检中心颁发的 “高通量测序实验室”技术审核,以及得美国CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品,推动肿瘤精准医疗领域的发展。
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology.
燃石医学(纳斯达克代码:BNR)成立于2014年,公司使命为“用科学守护生命之光”,专注于为肿瘤精准医疗提供具有临床价值的二代基因测序(NGS)。公司业务及研发方向主要覆盖:1)基于NGS的肿瘤患病人群检测,6年间,燃石累计检测样本超过18.5万例,在中国市场份额领跑行业;2)基于NGS的癌症早检,目前已经进入临床验证阶段。
燃石医学于2018年7月率先获国家药品监督管理局(NMPA)颁发的中国肿瘤NGS检测试剂盒,在体外诊断领域具有里程碑式意义。实验室获得广东省临检中心颁发的 “高通量测序实验室”技术审核,以及得美国CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品,推动肿瘤精准医疗领域的发展。
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology.
联系方式
- Email:simin.huang@brbiotech.com
- 公司地址:广州国际生物岛星岛环北路5号(燃石医学)
- 电话:17710099363